Sep 28, 2026 04:04PM
Sep 18, 2026 04:30PM
Sep 18, 2026 04:30PM
Aug 28, 2026 06:17AM
Aug 28, 2026 06:17AM
Aug 26, 2026 05:16PM
Aug 26, 2026 05:16PM Immuneering Comments on Today’s FDA Approval in Second-Line Metastatic Pancreatic Cancer, Reiterates Focus on First-Line Patients
Aug 19, 2026 04:05PM
Aug 19, 2026 08:56AM
Jul 29, 2026 07:42AM
Jul 29, 2026 07:24AM
Jul 13, 2026 03:27PM
Jun 18, 2026 04:58PM
Jun 18, 2026 04:56PM Teva Submits NDA for Ecopipam, a First-in-Class Investigational Therapy for Pediatric Tourette Syndrome
Jun 10, 2026 12:03PM
Jun 10, 2026 12:03PM
Jun 5, 2026 11:30AM
May 21, 2026 01:24PM
May 21, 2026 01:24PM
May 6, 2026 08:58AM
Apr 29, 2026 07:39AM Medincell - UZEDY®: Q1 2026 Net Sales Reached $63M, Up 62% Year‑on‑Year
Apr 29, 2026 06:30AM
Apr 29, 2026 06:30AM
Mar 9, 2026 10:53AM
Feb 20, 2026 03:38PM
Feb 20, 2026 03:37PM
Feb 20, 2026 02:43PM
Feb 20, 2026 02:43PM U.S. Food and Drug Administration (FDA) Accepts Teva’s New Drug Application (NDA) for Olanzapine Extended-Release Injectable Suspension (TEV-'749) for the Once-Monthly Treatment of Schizophreni
Feb 19, 2026 04:00PM
Jan 28, 2026 05:05PM
Jan 23, 2026 10:09AM
Jan 14, 2026 05:03PM
Jan 14, 2026 05:02PM
Jan 12, 2026 04:07AM
Jan 12, 2026 04:04AM TEVA secures $500 million funding from Royalty Pharma for vitiligo drug
Dec 22, 2025 07:06AM
Dec 19, 2025 03:30AM
Dec 12, 2025 10:47AM
Dec 9, 2025 08:02AM
Dec 9, 2025 08:00AM
Nov 5, 2025 07:00AM
Oct 24, 2025 08:29AM Piper Sandler: 'Biotech Has a Heartbeat: 17 Stocks to Own Through YE25'
Oct 10, 2025 04:11PM
Oct 10, 2025 04:11PM
Oct 10, 2025 03:00PM
Oct 10, 2025 03:00PM
Sep 23, 2025 12:52AM
Sep 17, 2025 08:01AM
Jul 30, 2025 07:00AM Teva's Innovative Portfolio Fuels 10th Consecutive Quarter of Growth in Q2 2025; Increases 2025 Revenue Outlook for Key Innovative Products and EPS, and Reaffirms All Other Components
Jun 18, 2025 08:45AM

332,796 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All